Similar articles for PMID: 17551313

Year	Number of Results
1993	1
1995	1
1996	3
1998	1
2001	2
2002	2
2003	4
2004	5
2005	5
2006	2
2007	6
2009	1
2010	2
2012	1
2013	3
2014	2
2018	2
2019	1
2024	0

1

Irinotecan with 5-FU/FA in advanced biliary tract adenocarcinomas: a multicenter phase II trial.

Feisthammel J, Schoppmeyer K, Mössner J, Schulze M, Caca K, Wiedmann M. Feisthammel J, et al. Am J Clin Oncol. 2007 Jun;30(3):319-24. doi: 10.1097/01.coc.0000258124.72884.7a. Am J Clin Oncol. 2007. PMID: 17551313 Clinical Trial.

2

A multicenter phase II trial with irinotecan plus oxaliplatin as first-line treatment for inoperable/metastatic cancer of the biliary tract.

Karachaliou N, Polyzos A, Kentepozidis N, Kakolyris S, Ziras N, Vardakis N, Kalykaki A, Milaki G, Georgoulias V, Androulakis N. Karachaliou N, et al. Oncology. 2010;78(5-6):356-60. doi: 10.1159/000320462. Epub 2010 Aug 26. Oncology. 2010. PMID: 20798557 Clinical Trial.

3

A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.

Ducreux M, Van Cutsem E, Van Laethem JL, Gress TM, Jeziorski K, Rougier P, Wagener T, Anak O, Baron B, Nordlinger B; EORTC Gastro Intestinal Tract Cancer Group. Ducreux M, et al. Eur J Cancer. 2005 Feb;41(3):398-403. doi: 10.1016/j.ejca.2004.10.026. Eur J Cancer. 2005. PMID: 15691639 Clinical Trial.

4

Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer.

Kuehr T, Ruff P, Rapoport BL, Falk S, Daniel F, Jacobs C, Davidson N, Thaler J, Boussard B, Carmichael J. Kuehr T, et al. BMC Cancer. 2004 Jul 16;4:36. doi: 10.1186/1471-2407-4-36. BMC Cancer. 2004. PMID: 15257756 Free PMC article. Clinical Trial.

5

Irinotecan combined or alternated with bolus 5-fluorouracil and folinic acid versus the Mayo Clinic regimen in the first-line therapy of advanced colorectal cancer.

Graeven U, Ridwelski K, Artandi M, Espana P, Schölmerich J, Rosales AM, Carlsson G, Borner M, Boussard B, Schmiegel W. Graeven U, et al. Oncol Rep. 2005 Apr;13(4):681-8. Oncol Rep. 2005. PMID: 15756442 Clinical Trial.

6

Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer.

Teufel A, Steinmann S, Siebler J, Zanke C, Hohl H, Adami B, Schroeder M, Klein O, Höhler T, Galle PR, Heike M, Moehler M. Teufel A, et al. BMC Cancer. 2004 Jul 20;4:38. doi: 10.1186/1471-2407-4-38. BMC Cancer. 2004. PMID: 15265233 Free PMC article. Clinical Trial.

7

A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.

Rosati G, Tucci A, Rinaldi A, Colarusso D, Pizza C, Reggiardo G, Manzione L. Rosati G, et al. Oncology. 2004;66(5):371-8. doi: 10.1159/000079485. Oncology. 2004. PMID: 15331924 Clinical Trial.

8

Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.

Cantore M, Mambrini A, Fiorentini G, Rabbi C, Zamagni D, Caudana R, Pennucci C, Sanguinetti F, Lombardi M, Nicoli N. Cantore M, et al. Cancer. 2005 Apr 1;103(7):1402-7. doi: 10.1002/cncr.20964. Cancer. 2005. PMID: 15726542 Free article.

9

FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience.

Moretto R, Raimondo L, De Stefano A, Cella CA, Matano E, De Placido S, Carlomagno C. Moretto R, et al. Anticancer Drugs. 2013 Oct;24(9):980-5. doi: 10.1097/CAD.0b013e328364e66b. Anticancer Drugs. 2013. PMID: 23928570

10

Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).

Gebbia V, Majello E, Testa A, Pezzella G, Giuseppe S, Giotta F, Riccardi F, Fortunato S, Colucci G, Gebbia N. Gebbia V, et al. Cancer. 1996 Sep 15;78(6):1300-7. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1300::AID-CNCR19>3.0.CO;2-4. Cancer. 1996. PMID: 8826954 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

42 results

Results by year